Ascendia Pharma

Ascendia Pharma is a specialty contract development and manufacturing organization (CDMO) that provides formulation services for difficult-to-distribute drug candidates. The company specializes in improving the solubility and bioavailability of small molecules and biologics using its proprietary technology platforms: EmulSol, AmorSol, NanoSol, and LipidSol. Ascendia offers a comprehensive suite of services ranging from pre-formulation and formulation development to cGMP manufacturing for clinical trials. Their expertise spans various dosage forms, including oral, injectable, and topical deliveries, with a particular focus on long-acting injectables and complex formulations. By addressing challenging drug delivery hurdles, Ascendia helps pharmaceutical and biotech partners accelerate their drug development timelines.